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A B S T R A C T
A 65-year-old man with a history of hypertension was admitted to our hospital with fainting and
syncope. He had experienced recurrent syncope since 20 years of age. On admission, systolic heart
murmur was audible at the apex of the heart. Echocardiography revealed anteriorly displaced papillary
muscles (PMs), elongation of the anterior mitral valve leaﬂet (AML), and systolic anterior motion (SAM)
of the AML. Color Doppler imaging showed accelerated ﬂow with a pressure gradient (PG) of 56 mmHg at
the left ventricular outﬂow tract (LVOT). Cardiac magnetic resonance imaging revealed mild asymmetric
septal hypertrophy and multiple accessory PMs. Cine images clearly demonstrated SAM and LVOT
obstruction due to anteriorly displaced PMs. Based on these ﬁndings, the patient was diagnosed as
having hypertrophic cardiomyopathy and LVOT obstruction due to abnormal PMs. Oral administration of
bisoprolol (2.5 mg/day) was initiated, because the patient rejected surgical treatment. Follow-up
echocardiography revealed a gradual decrease in the LVOT-PG to 24 mmHg, and no episodes of fainting
or syncope have recurred for 2 years after the initiation of bisoprolol.
<Learning objective: Abnormal papillary muscle (PM) is an unusual cause of left ventricular outﬂow
tract (LVOT) obstruction, and cardiac magnetic resonance (CMR) imaging has been reported to be useful
for diagnosis of abnormal PM. Abnormal PMs with LVOT obstruction are usually treated by surgical
correction, and therefore, reports on medical treatment are limited. We report a case of LVOT obstruction
due to abnormal PMs, which was accurately diagnosed by CMR imaging and successfully treated with a
beta-blocker.>
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Abnormal papillary muscle (PM) is an unusual cause of left
ventricular outﬂow tract (LVOT) obstruction [1], and is often
found in patients with hypertrophic cardiomyopathy (HCM)
[2]. Cardiac magnetic resonance (CMR) imaging has been reported
to be useful for diagnosis of abnormalities of the PM and mitral
valve in HCM patients [3–5]. Abnormal PMs with LVOT obstruc-
tion are usually treated by surgical correction [6,7], and therefore,
reports on medical treatment are limited [8]. In the present report,
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nosed by CMR imaging and successfully treated with a beta-
blocker.
Case report
A 65-year-old man with a history of hypertension was admitted
to our hospital with fainting and syncope. The patient had
experienced recurrent syncope since 20 years of age, and was
diagnosed with epilepsy at 49 years of age. Treatment with
anticonvulsants was soon discontinued because of skin rash. He
had been taking amlodipine (5 mg/day) for hypertension. On
admission, his blood pressure was 158/93 mmHg, pulse rate was
61 beats per minute, and systolic heart murmur of grade 4/6 was
audible at the apex of the heart. Chest radiography showed mild
cardiomegaly, and electrocardiography showed high voltage and
mild ST-segment depression. Transthoracic echocardiography reserved.
Fig. 1.
Echocardiography on admission. (A) Parasternal long-axis view. Left ventricular hypertrophy was not apparent. (B) Parasternal short-axis view of the mid-left
ventricle showing two anteriorly displaced papillary muscles (PM1 and PM2) (yellow arrows). (C) M-mode recording at the mitral valve level showing systolic
anterior motion of the anterior mitral valve leaﬂet (AML) (yellow arrows). (D) Apical long-axis view showing elongation of the AML and protrusion of the AML into
the left ventricular outﬂow tract (LVOT) (yellow arrow). (E) Color ﬂow imaging showing accelerated ﬂow at the LVOT (yellow arrow). The LVOT pressure gradient,
measured by continuous wave Doppler, was 56 mmHg. IVS, interventricular septum; PW, posterior wall; LV, left ventricle; LA, left atrium; Ao, aorta.
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12 mm, posterior wall: 10 mm, septal/posterior wall thickness
ratio: 1.2), dimension (end-diastolic: 41 mm, end-systolic: 22 mm),
and contractility (ejection fraction: 77%) (Fig. 1A). Parasternal short-
axis views of the left ventricle showed two anteriorly displaced PMs
(Fig. 1B). M-mode recording at the mitral valve level showed systolic
anterior motion (SAM) of the anterior mitral valve leaﬂet (AML)
(Fig. 1C). Apical long-axis views showed elongation of the AML and
protrusion of the AML into the LVOT (Fig. 1D). Color ﬂow imaging
showed accelerated ﬂow at the LVOT and continuous wave Doppler
recorded a pressure gradient (PG) of 56 mmHg (Fig. 1E). CMR
imaging revealed mild asymmetric septal hypertrophy (anterior
septal wall: 14.1 mm, posterior wall: 6.9 mm) which was not
apparent on echocardiography, and conﬁrmed the presence of
multiple accessory PMs, some of which were displaced anteriorly
(Fig. 2A). Cine images clearly displayed SAM and LVOT obstruction
due to anteriorly displaced PM (Fig. 2B–E). Left ventricular pressure
measured at the apex of left ventricle and LVOT showed a PG of
40 mmHg (Fig. 3). Coronary angiography showed no signiﬁcant
stenosis. Based on these ﬁndings, the patient was diagnosed as
having HCM and LVOT obstruction due to abnormal PMs. Oral
administration of bisoprolol (2.5 mg/day) was initiated, because the
patient rejected surgical treatment. The daily dose of bisoprolol was
maintained at 2.5 mg because of bradycardia. Follow-up echocardi-
ography performed 6 months and 2 years after the initiation of
bisoprolol revealed a gradual decrease in the LVOT-PG to 42 and
24 mmHg, respectively. The systolic heart murmur also decreased tograde 2/6. In addition, no episodes of fainting or syncope recurred for
2 years after the initiation of bisoprolol.
Discussion
Hypertrophic obstructive cardiomyopathy is a common cause
of LVOT obstruction, whereas abnormal PM, although unusual, has
been reported to cause LVOT obstruction [1]. Roberts and Cohen
classiﬁed abnormal PM morphology into the following groups:
single PM, accessory PMs, abnormally large (or small) and
malpositioned PM, and insertion of the PM directly into the mitral
leaﬂet [9]. In the present case, the number of PMs was high, and a
few of these PMs were anteriorly displaced; thus, the patient was
diagnosed as having accessory PMs and malpositioned PMs.
Although left ventricular hypertrophy was not apparent on
echocardiography, CMR imaging revealed mild asymmetric septal
hypertrophy; thus, the patient was diagnosed as having HCM.
Previous studies reported that abnormalities of the PM and mitral
valve were often found in patients with HCM [2], and CMR was
useful for diagnosis of these abnormalities [3–5]. Harrigan et al.
evaluated PM morphology in 201 patients with HCM using CMR
imaging, and indicated that PM number and mass were increased
in HCM patients, and anteriorly displaced PMs were associated
with LVOT obstruction [3]. Furthermore, Kwon et al. assessed the
relationship between abnormal PM morphologies and LVOT
obstruction in 56 patients with HCM using CMR, and noted that
patients with anteroapically displaced PMs had higher LVOT-PG,
Fig. 2.
Cardiac magnetic resonance imaging. (A) Short-axis images of the left ventricle showing multiple accessory papillary muscles; PM1 and PM2 indicate two
anteriorly displaced papillary muscles (yellow arrows). The measured regional wall thicknesses are shown in the image. (B–E) Cine images of four-chamber long-
axis views showing the motion of PM1 during early to late systole (B ! C ! D ! E). The systolic anterior motion of the anterior mitral valve leaﬂet (AML) and the
left ventricular outﬂow tract narrowing by the anteriorly displaced papillary muscle (PM1) were clearly observed.
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abnormal PM and LVOT obstruction who had mild or no septal
hypertrophy were reported [6–8]. Using experimental dog models,
Levine et al. demonstrated that the anterior displacement of the
PM could cause SAM without septal hypertrophy, suggesting that
PM displacement and mitral leaﬂet slack may be the main causes ofFig. 3.
Left ventricular pressure measured at the apex of left ventricle (LV) and the left
LVOT was 40 mmHg.SAM in HCM [10]. In the present case, septal hypertrophy was not
severe, and therefore, PM displacement and AML elongation were
considered to be the main cause of LVOT obstruction.
Abnormal PMs with LVOT obstruction are usually treated by
surgical correction [6,7], and therefore, only a few reports have
described the efﬁcacy of medical treatments in patients with LVOT ventricular outﬂow tract (LVOT). The pressure gradient between the apex of LV and
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metoprolol 100 mg daily to treat a patient with LVOT obstruction
due to abnormal PMs; in this patient, a decrease in the LVOT-PG
and symptomatic improvement was noted [8]. Similarly, in the
present case, the LVOT-PG decreased and symptoms resolved after
the initiation of beta-blocker therapy. Exercise stress or amyl
nitrate consumption would increase LVOT-PG in patients with
LVOT obstruction due to abnormal PMs [7,8], suggesting that the
hemodynamic characteristics may be similar between LVOT
obstruction due to abnormal PMs and hypertrophic obstructive
cardiomyopathy. Beta-blockers have been considered to be the
ﬁrst-line therapy for hypertrophic obstructive cardiomyopathy.
The ﬁndings of the present case suggest that beta-blockers might
be a useful treatment for LVOT obstruction due to abnormal PMs,
although this should be conﬁrmed by future clinical studies.
Conclusion
We report a case of LVOT obstruction due to abnormal PMs,
which was accurately diagnosed by CMR imaging and successfully
treated with a beta-blocker. Although transthoracic echocardiog-
raphy is the most useful for diagnosis and follow-up for patients
with HCM, CMR imaging could provide more detailed information
about abnormal PMs and LVOT obstruction. Beta-blockers might
be effective for reducing LVOT-PG in patients with LVOT
obstruction due to abnormal PMs.
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